The first book publishes links between a variety of heart and metabolic conditions and COVID19, highlighting challenges faced by the global scientific community
Online PR News – 25-February-2022 – London, United Kingdom – A cardiologist and researcher from London, United Kingdom has published a book entitled "Cardiovascular Complications of COVID19: Risk, Pathogenesis and Outcomes" with Springer Nature Publishers Group. The link: https://link.springer.com/book/10.1007/978-3-030-90065-6?page=2#toc
This book reveals the emerging literature and presents an overview of COVID19 from a cardiovascular perspective. It highlights the main epidemiological, virological, pathogenetic, and clinical features of COVID19, and compiles state of the art information derived from the most recent evidence from COVID19 research.
This is the first book that discusses the evidence behind the relationship between COVID19 and heart disease and publishes links between a variety of heart and metabolic conditions and COVID19, highlighting challenges faced by the global scientific community. The rapid and unexpected global spread of the COVID19 has revealed proportional levels of cardiovascular and metabolic complications.
A myriad of pathogenetic mechanisms has come to the surface. There is still much research required to define whether cardiovascular disease causes COVID19 complications or that cardiovascular disease appears as a result of the infection and which mechanisms are responsible. With cardiovascular and metabolic diseases already at pandemic levels and expected to increase further, this book provides readers with an urgent and thorough analysis of this association.
Cardiovascular Complications of COVID19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID19, highlighting the association between these pandemics and including risk factors, mechanisms, and how these may impact diverse patients populations. It describes how COVID19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus while providing an overview of the observed gender dichotomy among patients. It, therefore, represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID19.
The book also explores links between older age and COVID19, the gender gap observed in COVID19, and several other important issues faced by clinicians, researchers, and scientists worldwide. The book reveals that individuals with heart disease or at risk of heart disease, obese subjects, or diabetics especially the older males more often develop complications due to COVID19, carry a higher risk of death, and frequently require intensive care support. It helps understand the key mechanisms that underlie the associated complications that are also responsible for higher rates of hospital admissions and may be responsible for death due to COVID19 in certain population groups.
According to the author Dr. Umair Mallick, the SARS CoV2 viral invasion induces a variety of intense immune-inflammatory and prothrombotic mechanisms, and there is dysregulation of the body's physiological mechanisms that control the internal environment of the body systems that ultimately result in harm to the internal organs. The lungs appear to act as a core to the spread of these mechanisms. The book reveals these and other important cellular mechanisms that contribute to the complications associated with COVID19.
This book further highlights an important message to the high-risk individuals including the elderly, diabetics, obese, and patients with heart disease, to take extra precautionary measures for prevention of COVID19, and seek early treatment if they contract COVID19. These findings further reflect the need for vaccination against the COVID19 that offers protection against the disease. It provides a clear message to the scientific and research community to work together for a better understanding of the novel coronavirus disease that is impacting healthcare systems and presenting a huge economic burden to the worldwide community, especially the low-middle income economies.